Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
22.27
-2.31 (-9.40%)
At close: Apr 23, 2026, 4:00 PM EDT
22.43
+0.16 (0.72%)
After-hours: Apr 23, 2026, 7:55 PM EDT

Summit Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
265
Market Cap
17.28B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022705.00K-1.10M-61.03%
Dec 31, 20211.81M949.00K110.35%
Dec 31, 2020860.00K-56.23M-98.49%
Dec 31, 201957.09M--
Jan 31, 201957.09M39.54M225.24%
Jan 31, 201817.55M14.65M505.12%
Jan 31, 20172.90M--
Jan 31, 2016---
Jan 31, 2015---
Jan 31, 2014---
Jan 31, 20132.88M2.57M847.80%
Jan 31, 2010303.40K37.67K14.18%
Jan 31, 2009265.73K-5.76M-95.59%
Jan 31, 20086.03M4.00M197.42%
Jan 31, 20072.03M1.08M114.52%
Jan 31, 2006944.36K731.95K344.60%
Jan 31, 2005212.41K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Incyte5.14B
Genmab3.72B
BioNTech SE3.37B
Royalty Pharma2.38B
Moderna1.94B
Ionis Pharmaceuticals943.71M
Ascendis Pharma845.52M
Insmed606.42M
Revenue Rankings